Sarsoza, Ayesha .

HRN: 19-80-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/08/2022
07/15/2022
IV
325
Q6H
PCAP C
Waiting Final Action 
07/09/2022
CEFTRIAXONE 1G (VIAL)
07/09/2022
07/15/2022
IVT
650mg
Q24 X 7 Days
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: